Intermediate for Efinaconazole. Efinaconazole (trade names: Jublia and Clenafin) is a 14α-demethylase inhibitor for the treatment of onychomycosis (fungal infection of the nail). Efinaconazole has been approved by the U.S Food and Drug Administration on June 6, 2014.
Product Name: (2R)-1-(2,4-Difluorophenyl)-2-((tetrahydro-2H-pyran-2-yl)oxy)propan-1-one
CAS Number: 126918-17-0
Molecular Weight:  270.2754
Molecular Formula:  C14H16F2O3
Purity (HPLC): ≥95%
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.